Our findings, drawn from extensive analyses of multiple datasets, IHC, and IF staining in both human and murine specimens, highlight STMN1’s potential as a diagnostic marker and therapeutic target for this challenging subtype of PCa. This evidence concerns the gene STMN1 and posterior cortical atrophy.